Atlas Trials

Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes

Clinical trial NCT01960179 · COMPLETED

Trial details

NCT number
NCT01960179
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2013-11-01
Primary completion
2015-03-01
Enrollment
361

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.